Ipamorelin

Characteristics

How does Ipamorelin work?

Ipamorelin is a selective agonist of the ghrelin receptor (GHS-R1a) and stimulates the release of growth hormone (GH) from the anterior pituitary gland. Unlike other GH secretagogues, Ipamorelin does not significantly increase levels of adrenocorticotropic hormone (ACTH), cortisol, or prolactin. This selectivity makes Ipamorelin a promising research peptide for studying the effects of GH secretion without the confounding effects of other hormones.

Ipamorelin binds to the GHS-R1a receptor, which is primarily expressed in the hypothalamus and pituitary gland. Upon binding, it triggers a cascade of signaling events that ultimately lead to the synthesis and secretion of GH. The released GH then binds to its receptors in various target tissues, such as the liver, muscle, and bone, to exert its anabolic effects.

Summary

Ipamorelin is a research peptide and selective ghrelin receptor agonist that stimulates the secretion of growth hormone (GH) from the pituitary gland. Animal studies have demonstrated its potential benefits in promoting GH release, regulating appetite, improving body composition, supporting bone health, and enhancing cardiovascular function. Ipamorelin's selectivity for GH secretion without significantly affecting other hormones makes it a promising research tool in the fields of endocrinology, metabolism, and aging. However, further research is needed to fully elucidate its mechanisms of action, potential therapeutic applications, and safety profile in mammalian models.

Resource